Buy MOTS-c Peptide 10mg — Best 99%+ Purity, Third-Party Tested, USA

Buy MOTS-c with complete confidence — every vial is independently HPLC tested to 99%+ purity, ships with a batch-specific Certificate of Analysis, and is made in the USA. When you buy MOTS-c from us, you get the most rigorously documented mitochondrial research peptide available online in 2026.

Why Researchers Buy MOTS-c — The Only Mitochondria-Encoded Peptide

When researchers buy MOTS-c, they are buying access to a compound unlike anything else in the peptide research space. MOTS-c — Mitochondrial Open Reading Frame of the 12S rRNA-c — is a 16-amino acid peptide encoded entirely within mitochondrial DNA, not nuclear DNA. Your mitochondria produce it themselves in response to energy stress, fasting, and exercise. No other commercially available research peptide shares this origin.

First published in Cell Metabolism in 2015 by Lee et al., MOTS-c works by activating AMPK — AMP-activated protein kinase — the master switch of cellular energy regulation. This is the same pathway triggered by intense exercise and by the pharmaceutical drug metformin. The downstream effects documented in preclinical models include enhanced glucose uptake in skeletal muscle, accelerated fat oxidation, improved insulin sensitivity, and mitochondrial biogenesis. Search volume for MOTS-c surged from 22,000 to over 60,000 monthly searches in 2026, driven entirely by genuine scientific momentum.

Purity matters more when you buy MOTS-c than with almost any other peptide. MOTS-c degrades through methionine oxidation — a process that accelerates with poor handling and substandard lyophilization. A supplier without rigorous cold-chain protocols and independent third-party testing is selling a compromised compound. Our batch-specific HPLC and Mass Spec COAs are publicly accessible before you order.

MOTS-c FDA Status April 2026 — What You Need to Know Before You Buy MOTS-c

On April 15, 2026, HHS Secretary Robert F. Kennedy Jr. directed the FDA to remove MOTS-c from the Category 2 bulk drug substances list — meaning it is no longer classified as raising significant safety concerns. This took effect April 22, 2026.

The next step is a PCAC review on July 23, 2026 at FDA White Oak, where MOTS-c will be evaluated for Category 1 status. Category 1 would allow licensed compounding pharmacies to prepare MOTS-c under physician prescription, dramatically increasing standardisation and legitimate access. For researchers who buy MOTS-c today from a reputable, third-party-tested supplier, this regulatory trajectory is the most favourable it has ever been.

MOTS-c remains a research-use-only (RUO) compound — not approved for human consumption. Competitive athletes in WADA-tested sports should note it remains prohibited under S4.4.1 as an AMPK activator. Source: FDA.gov official document ↗

MOTS-c Research: Four Documented Areas of Scientific Study

The peer-reviewed literature on MOTS-c spans four primary research domains, each backed by independent preclinical evidence:

MOTS-c 10mg — Full Research Specifications

Why Purity Is Critical When You Buy MOTS-c

Every batch is tested by an independent ISO/IEC 17025 accredited laboratory — never in-house. When you buy MOTS-c from us, testing covers:

• ✓Identity — Mass Spectrometry
• ✓Purity % — HPLC chromatography
• ✓Concentration accuracy
• ✓Heavy metals panel
• ✓Microbial limits test
• ✓Batch-specific COA issued

Buy MOTS-c vs. Humanin vs. SS-31 — Which Mitochondrial Peptide?

MOTS-c is one of only three known mitochondrial-derived peptides (MDPs). Researchers frequently ask how it compares to Humanin and SS-31 before they buy MOTS-c. The answer: they share a mitochondrial origin but target entirely different biological problems.

For researchers focused on metabolic health, insulin sensitivity, body composition, or physical performance — MOTS-c is the correct compound to buy. Read our full mitochondrial peptide comparison →

MOTS-c Research Dosing & Storage Context

The following is provided strictly for research reference. This product is sold for laboratory use only. Not for human consumption.

The published preclinical literature applies doses of 5–15 mg/kg intraperitoneally in rodent models. Community research protocols typically apply allometric scaling, with 5–10 mg per administration cited most frequently. The landmark 2021 Nature Communications study (PMID: 33473109 ↗) applied an intermittent schedule of 3 administrations per week in late-life mouse models and produced measurable healthspan improvements.

MOTS-c has a short estimated in vivo half-life — exercise-induced endogenous MOTS-c in humans returns to baseline within approximately 4 hours. Reconstituted MOTS-c in bacteriostatic water shows no significant degradation for at least 30 days at 4°C (Mohtashami et al.).

MOTS-c Storage Protocol

• Lyophilized vial (before reconstitution): Refrigerate at 2–8°C. Stable up to 24 months. Keep away from light and moisture.
• After reconstitution: Use within 7 days at 2–8°C. For extended research, aliquot into single-use volumes and freeze at −20°C.
• Critical — avoid freeze-thaw cycles: Methionine oxidation is MOTS-c’s primary degradation pathway. Pre-aliquoting before freezing eliminates this risk entirely.

MOTS-c Research Stacking Context

For research context only. Not medical advice.

Community and clinical research literature describes MOTS-c as mechanistically compatible with several research compound combinations. The most documented pairings when researchers buy MOTS-c:

• MOTS-c + CJC-1295 / Ipamorelin: CJC-1295 with Ipamorelin stimulates growth hormone via GHRH and ghrelin receptor pathways. MOTS-c’s AMPK-mediated mechanism is non-overlapping — frequently studied together in body composition research.
• MOTS-c + BPC-157: BPC-157 operates through nitric oxide and growth factor pathways in tissue repair research. No mechanistic conflict with MOTS-c’s mitochondrial energy axis has been identified in published literature.
• MOTS-c + Epitalon: Epitalon activates telomerase through an entirely distinct pathway from AMPK. Frequently co-studied in longevity research given complementary, non-redundant mechanisms.
• MOTS-c standalone: The 2021 Nature Communications study produced significant healthspan results with MOTS-c alone at 3× weekly — no stack required for measurable preclinical outcomes.

Browse all longevity and metabolic research peptides →

Frequently Asked Questions — Buy MOTS-c

• 
  Is it legal to buy MOTS-c in the USA in 2026?
  +
  
  Yes. You can buy MOTS-c legally in the USA for laboratory research purposes. It is classified as a research-use-only (RUO) compound. On April 22, 2026, the FDA formally removed MOTS-c from Category 2 — it is no longer classified as raising significant safety concerns. A PCAC hearing is scheduled for July 23, 2026. It is not approved for human consumption. WADA-tested athletes should note it remains prohibited under S4.4.1. Source: FDA.gov ↗
• 
  What purity should I look for when I buy MOTS-c?
  +
  
  When you buy MOTS-c, always look for independent third-party HPLC verification of 99%+ purity and Mass Spectrometry identity confirmation. Every batch we sell meets this standard. Batch-specific COAs are publicly posted on our lab reports page — verify your lot number before ordering. Never buy MOTS-c from a supplier that cannot provide a batch-specific, independently verified COA.
• 
  What is MOTS-c and why should I buy MOTS-c for research?
  +
  
  MOTS-c is a 16-amino acid peptide encoded within the mitochondrial 12S rRNA gene — one of only three known mitochondrial-derived peptides. Researchers buy MOTS-c because its primary mechanism — AMPK activation in skeletal muscle — is unique to this compound. This drives glucose uptake, fat oxidation, improved insulin sensitivity, and mitochondrial biogenesis in preclinical models. No other research peptide targets this same pathway from a mitochondrial origin.
• 
  How should MOTS-c be stored after I receive it?
  +
  
  Lyophilized MOTS-c: refrigerate at 2–8°C, stable up to 24 months. After reconstitution with bacteriostatic water: use within 7 days at 2–8°C, or aliquot and freeze at −20°C for extended research windows. Critical: avoid repeated freeze-thaw cycles. Methionine oxidation is MOTS-c’s primary degradation pathway — pre-aliquoting before freezing eliminates this risk entirely.
• 
  Does MOTS-c cross the blood-brain barrier?
  +
  
  No. Research confirms peripherally administered MOTS-c does not cross the blood-brain barrier. Cognitive effects seen in certain studies occurred only with direct intracranial administration in controlled laboratory settings — not applicable to standard subcutaneous or intraperitoneal research protocols. Do not expect nootropic effects from peripheral MOTS-c research.
• 
  How does MOTS-c compare to metformin?
  +
  
  Both activate AMPK, producing overlapping metabolic effects in some models. However, MOTS-c primarily targets skeletal muscle while metformin primarily targets the liver. Their downstream signalling and probable side-effect profiles differ due to these distinct tissue preferences — making them interesting subjects for comparative metabolic research rather than direct equivalents.
• 
  What solvent do I use to reconstitute MOTS-c?
  +
  
  Bacteriostatic water is recommended. It allows multiple withdrawals while maintaining sterility — ideal for multi-session research protocols. Standard water for injection can be used for single-use protocols. Gently swirl until dissolved; do not vortex or shake vigorously as this may accelerate peptide degradation.

Published Research & Scientific References

All references link directly to PubMed or the original publisher for independent verification. These are the primary studies that validate MOTS-c as a research compound.

1. Lee C, et al. (2015). The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism, 21(3), 443–454. PMID: 25738459 ↗ — Original MOTS-c discovery: AMPK activation mechanism, obesity prevention in high-fat diet model, metabolic homeostasis regulation.
2. Reynolds JC, et al. (2021). MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nature Communications, 12, 470. PMID: 33473109 ↗ — Physical performance improved at every life stage in mice; MOTS-c expression confirmed in human skeletal muscle during exercise; late-life treatment improved healthspan markers.
3. Lu H, et al. (2022). MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation. Frontiers in Endocrinology. PMC9905433 ↗ — Comprehensive review: aging, cardiovascular disease, insulin resistance, inflammation, and synthetic biology development pathways.
4. Mohtashami Z, et al. (2022). Stability analyses of exogenous MOTS-c peptides via high-resolution mass spectrometry. — Reconstituted MOTS-c stable for ≥30 days at 4°C; methionine oxidation confirmed as primary degradation pathway.
5. FDA / SSRP Institute (April 15, 2026). FDA removes MOTS-c from Category 2 bulk drug substances list. PCAC review scheduled July 23, 2026. FDA.gov official source ↗